Seasoned Industry Veteran Brings Over 20 Years of Biotechnology and Pharmaceutical Development Experience, With Deep Expertise in Development of Ophthalmology Drugs
Previously Served in Executive Leadership Roles at BridgeBio Pharma, Clearside Biomedical and Alcon, formerly the Ophthalmology subsidiary of Novartis
PR Newswire
PERTH, Australia and NEW YORK, Feb. 23, 2021